If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
187.50    0.50 (0.27%)
Bid:
185.00
Ask:
190.00
Spread: 5.00 (2.703%)
Market Cap: £97.08m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

7 Jan 2016 07:00

RNS Number : 0828L
Somero Enterprises Inc.
07 January 2016
 

7 January 2016

Somero Enterprises, Inc.

("Somero" or the "Company")

 

Trading update

 

Somero is pleased to provide the following update on trading for the financial year ended 31 December 2015.

 

In the six months since 30 June 2015, the Company performed strongly, particularly in the final quarter with monthly sales at an all-time high in December, which is not traditionally the strongest month of the year. As a result, the Board is pleased to announce that the Company now expects to report Revenue ahead of current market expectations for the full year. Furthermore, as a result of an improved gross margin performance, the Company now expects to report EBITDA materially ahead of current market expectations for the period.

 

Demand in the second half of 2015 has remained robust across our core product range with North America and Europe contributing significantly to sales growth while performance in China was healthy and remained stable. The particularly strong finish to the year in Europe and full year performance in the Middle East notably exceeded the Board's prior expectations.

 

The year-end demand for the Company's products in North America was predominantly driven by technology upgrades and fleet additions, highlighting lengthy project backlogs for our customers that extend well into 2016.

 

On a product basis, while large line machine sales continue to represent the majority of our volume, small-line revenues, including the S-485 introduced at the end of 2014, were key contributors to growth.

 

While it is too early to provide detailed guidance for 2016, the Board is confident that it will deliver another year of growth and that the high-level of activity in December will continue into 2016 providing a solid start to the year.

 

Somero's final results for the year ending 31 December 2015 will be announced on 1 March 2016. 

 

 

For further information, please contact:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, CFO

Howard Hohmann, EVP Sales

 

Canaccord Genuity Ltd (NOMAD and Joint Broker)

Bruce Garrow +44 (0)20 7523 8000

Piers Coombs

Mark Whitmore

 

finnCap Ltd (Joint Broker)

Matt Goode +44 (0)20 7220 0500

Carl Holmes

Tim Redfern

 

Redleaf Communications Ltd (Financial PR Advisor) somero@redleafpr.com

Rebecca Sanders-Hewett +44 (0)20 7382 4730

David Ison

Susie Hudson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKADBKBKBCDK
Date   Source Headline
5th Jul 20234:52 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 20237:00 amRNSTrading Update
14th Jun 20233:46 pmRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20233:10 pmRNSResult of AGM
17th May 20236:10 pmRNSTransaction in Own Shares and Total Voting Rights
17th May 20237:00 amRNSAGM Statement
12th May 20232:26 pmRNSTransaction in Own Shares and Total Voting Rights
4th May 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20236:15 pmRNSUpdate re: RSUs & Director/PDMR Shareholding
26th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Apr 20237:00 amRNSAnnual Report and Notice of AGM
24th Mar 20237:00 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSRestricted Stock Units& Director/PDMR Shareholding
8th Mar 20237:00 amRNSFinal Results
15th Feb 20237:00 amRNSNotice of Investor Presentation
2nd Feb 20233:54 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSTrading Update
11th Oct 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Oct 20227:00 amRNSUpdate following Hurricane Ian
28th Sep 20225:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20227:00 amRNSHolding(s) in Company
23rd Sep 20227:00 amRNSHolding(s) in Company
22nd Sep 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Sep 20225:21 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Sep 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20226:02 pmRNSTransaction in Own Shares and Total Voting Rights
11th Aug 20222:26 pmRNSNotice of Investor Presentation
5th Aug 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20225:37 pmRNSTransaction in Own Shares
20th Jul 20222:05 pmRNSSecond Price Monitoring Extn
20th Jul 20222:00 pmRNSPrice Monitoring Extension
20th Jul 202211:00 amRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jul 20225:08 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Jun 20224:59 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20225:46 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jun 20227:00 amRNSAGM Statement
8th Jun 20221:22 pmRNSHolding(s) in Company
7th Jun 20226:00 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.